Aafke Eggink-Meerveld

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.

Journal: The New England journal of medicine

Published: June 03, 2024

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.

Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.

Journal: Journal for immunotherapy of cancer

Published: January 15, 2024

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Journal: The New England journal of medicine

Published: December 08, 2022

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.

Journal: Clinical genitourinary cancer

Published: November 23, 2022

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment.

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment.

Journal: European urology open science

Published: November 10, 2021

Persistent changes in circulating white blood cell populations after splenectomy.

Persistent changes in circulating white blood cell populations after splenectomy.

Journal: International journal of hematology

Published: March 20, 2017

Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.

Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.

Journal: Vaccine

Published: August 31, 2016

Short-term CTLA-4 blockade directly followed by PD-1 blockade in advanced melanoma patients: a single-center experience.

Short-term CTLA-4 blockade directly followed by PD-1 blockade in advanced melanoma patients: a single-center experience.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 05, 2016

Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.

Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.

Journal: The Netherlands journal of medicine

Published: November 13, 2013

Bone metastases or an insufficiency fracture? Oncology patients reporting pain or showing bone abnormalities on a scan

Bone metastases or an insufficiency fracture? Oncology patients reporting pain or showing bone abnormalities on a scan

Journal: Nederlands tijdschrift voor geneeskunde

Published: July 12, 2013

Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.

Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.

Journal: Vaccine

Published: July 02, 2013

Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.

Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: June 28, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026